Choriocarcinoma (Gestational Trophoblastic Neoplasia) drugs in development, 2023

GlobalData tracks 5 drugs in development for Choriocarcinoma (Gestational Trophoblastic Neoplasia) by four companies/universities/institutes. The top development phase for Choriocarcinoma (Gestational Trophoblastic Neoplasia) is phase i, with four drugs in that stage.

Stryker touts Mako robot in DTC ads, as device makers eye broader patient populations

Dive Brief: Stryker is rolling out a direct-to-patient marketing campaign aimed at promoting the advantages of its Mako surgical robot to people with joint pain

August 9, 2023

Sangamo’s stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership – Pharmaceutical Technology

Shares in Sangamo lost 50% of their value in after-hours trading following the announcement, which came just before the close on 30 December. Credit: jayk7

January 3, 2025

New research highlights potential of cytisine for global smoking cessation efforts

A new study published in Addiction has found that cytisine, a low-cost, generic stop-smoking aid that has been used in eastern Europe since the 1960s,

January 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.